Quick Answer
MACROGENICS INC reported Cash and Equivalents of $57.22 million for fiscal year 2025.
MACROGENICS INC Cash and Equivalents — Annual History
| Fiscal Year | Cash and Equivalents | YoY Change |
|---|---|---|
| 2025 | $57.22M | -68.7% |
| 2024 | $182.84M | +81.1% |
| 2023 | $100.96M | -7.3% |
| 2022 | $108.88M | -11.8% |
| 2021 | $123.47M | -31.8% |
| 2020 | $181.13M | +43.2% |
| 2019 | $126.47M | -42.5% |
| 2018 | $220.13M | +4.0% |
| 2017 | $211.73M | +151.8% |
| 2016 | $84.10M | -57.1% |
| 2015 | $196.17M | +24.5% |
| 2014 | $157.59M | +35.3% |
| 2013 | $116.48M | +144.0% |
| 2012 | $47.74M | -13.5% |
| 2011 | $55.22M | +49.7% |
| 2010 | $36.88M | — |
Quarterly Cash and Equivalents
| Quarter Ending | Cash and Equivalents | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $80.13M | -55.4% | -38.7% |
| June 30, 2025 | $130.69M | +55.7% | -10.2% |
| March 31, 2025 | $145.57M | +81.2% | -20.4% |
| December 31, 2024 | $182.84M | +81.1% | +1.8% |
| September 30, 2024 | $179.62M | +99.8% | +114.0% |
| June 30, 2024 | $83.93M | -22.8% | +4.5% |
| March 31, 2024 | $80.36M | -64.2% | -20.4% |
| December 31, 2023 | $100.96M | -7.3% | +12.3% |
- MACROGENICS INC showed a decrease of -68.7% in Cash and Equivalents compared to the prior fiscal year.
- Over the 2010–2025 period, MACROGENICS INC’s cash and equivalents has grown by 55.2% (from $36.88 million to $57.22 million).
- The most recent figure is from MACROGENICS INC’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 9, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: